Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 26 min ago
Peer-reviewedCC BY 4.0BMC Pediatrics

Sex-specific adverse neonatal outcomes and umbilical cord arterial ph at birth: a population-based cohort study

  1. 1Department of Obstetrics and Gynaecology, Skåne University Hospital, Malmö, 205 01 Sweden
  2. 2Obstetrics and Gynaecology, Institution of Clinical Sciences Lund, Lund University, Lund, Sweden

Abstract

Background: Biological sex may influence neonatal vulnerability to adverse perinatal outcomes, but sex-related differences in these outcomes remain underexplored. Male neonates may be more susceptible to perinatal asphyxia, metabolic acidosis, preterm birth, and morbidity, possibly due to sex-specific placental differences and inflammatory responses. Umbilical cord arterial pH (UApH) < 7.05 is used in Sweden to define neonatal acidemia, associated with poor outcomes. This study aimed to investigate the association between neonatal sex and adverse outcomes, focusing on UApH.

Methods: This retrospective multicenter cohort study used data from the Swedish Perinatal Revision South Register (1995–2015). The cohort included live-born, singleton, vaginal births. Neonatal and maternal data were extracted, and logistic regression models compared outcomes between male and female neonates, adjusting for maternal age, gestational age, and birth weight.

Results: Among 87 840 neonates, 51.6% were male. Male neonates had significantly higher adjusted odds of adverse outcomes compared with females: UApH < 7.05 (OR 1.18, 95% CI 1.07–1.30; P < 0.001), Apgar score < 7 at 5 min (OR 1.33, 95% CI 1.14–1.56; P < 0.001), CPAP use (OR 1.66, 95% CI 1.46–1.87; P < 0.001), NICU admission (OR 1.51, 95% CI 1.43–1.60; P < 0.001), hypoxic-ischemic encephalopathy (OR 2.24, 95% CI 1.29–3.90; P = 0.002) and central nervous system disease (OR 1.52, 95% CI 1.30–1.76; P < 0.001).

Conclusions: Male neonatal sex was associated with several adverse perinatal outcomes, including acidemia and neurological complications. These findings contribute to the understanding of sex-related differences in neonatal vulnerability and warrant further investigation.

Trial registration: Not applicable.

Related

  1. Umbilical cord arterial blood pH versus lactate for prediction of early neonatal outcomes in high-risk term newborns: A hospital-based observational study
    Ela Chauhan, Ritu Rakholia, Pooja Agarwal +2
    Asian Journal of Medical SciencesPeer-reviewedCC BY-NCFull textGeneral medicineDOAJ
  2. Downregulation of alcohol dehydrogenase family proteins suggests disrupted retinol metabolism in neonatal respiratory distress syndrome: an umbilical cord blood proteomics study
    Jing Wang, Ying Wei, Xuan Kan +1
    Frontiers in pediatricsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Umbilical Cord Methadone and Buprenorphine Levels and Neonatal Opioid Withdrawal Severity
    Courtney Townsel, Makeda Turner, Fatemeh Biroon +4
    JAMA Network OpenPeer-reviewedCC BY-NC-NDFull textObstetrics, gynaecology & paediatricsCrossrefEurope PMCPMC
  4. Maternal characteristics and neonatal outcomes in twin pregnancies in Brazil: A nationwide population-based study, 2015–2024
    Thaísa Bissoli, Thais Rangel Bousquet Carrilho, Nathalia Ferreira Antunes de Almeida +1
    PLOS OnePeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsPLOS
  5. Understanding vulnerability to reproductive, maternal, neonatal and child health outcomes in Senegal using a population segmentation
    Palash Singh, Finou Thérèse Mendy, Camille Kramer Courbariaux +12
    BMC Public HealthPeer-reviewedCC BY 4.0Obstetrics, gynaecology & paediatricsCrossref
BibTeX
@article{akel2026sexspecific,
  title = {{Sex-specific adverse neonatal outcomes and umbilical cord arterial ph at birth: a population-based cohort study}},
  author = {Wazhma Nassery Akel and Sara Abdulilah and Mehreen Zaigham},
  journal = {BMC Pediatrics},
  year = {2026},
  month = oct,
  doi = {10.1186/s12887-026-07865-5},
  url = {https://doi.org/10.1186/s12887-026-07865-5},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Sex-specific adverse neonatal outcomes and umbilical cord arterial ph at birth: a population-based cohort study
AU  - Wazhma Nassery Akel
AU  - Sara Abdulilah
AU  - Mehreen Zaigham
PY  - 2026
DA  - 2026/10/27
JO  - BMC Pediatrics
DO  - 10.1186/s12887-026-07865-5
UR  - https://doi.org/10.1186/s12887-026-07865-5
AB  - Background: Biological sex may influence neonatal vulnerability to adverse perinatal outcomes, but sex-related differences in these outcomes remain underexplored. Male neonates may be more susceptible to perinatal asphyxia, metabolic acidosis, preterm birth, and morbidity, possibly due to sex-specific placental differences and inflammatory responses. Umbilical cord arterial pH (UApH) < 7.05 is used in Sweden to define neonatal acidemia, associated with poor outcomes. This study aimed to investigate the association between neonatal sex and adverse outcomes, focusing on UApH.  Methods: This retrospective multicenter cohort study used data from the Swedish Perinatal Revision South Register (1995–2015). The cohort included live-born, singleton, vaginal births. Neonatal and maternal data were extracted, and logistic regression models compared outcomes between male and female neonates, adjusting for maternal age, gestational age, and birth weight.  Results: Among 87 840 neonates, 51.6% were male. Male neonates had significantly higher adjusted odds of adverse outcomes compared with females: UApH < 7.05 (OR 1.18, 95% CI 1.07–1.30; P < 0.001), Apgar score < 7 at 5 min (OR 1.33, 95% CI 1.14–1.56; P < 0.001), CPAP use (OR 1.66, 95% CI 1.46–1.87; P < 0.001), NICU admission (OR 1.51, 95% CI 1.43–1.60; P < 0.001), hypoxic-ischemic encephalopathy (OR 2.24, 95% CI 1.29–3.90; P = 0.002) and central nervous system disease (OR 1.52, 95% CI 1.30–1.76; P < 0.001).  Conclusions: Male neonatal sex was associated with several adverse perinatal outcomes, including acidemia and neurological complications. These findings contribute to the understanding of sex-related differences in neonatal vulnerability and warrant further investigation.  Trial registration: Not applicable.
SN  - 1471-2431
ER  -